Related Experiment Video
Updated: Aug 17, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Thrombophilia in children with venous thromboembolic disease
Shoshana Revel-Vilk1, Gili Kenet
1Pediatric Hematology/Oncology Unit, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem il-91200, Israel. shoshanav@hadassah.org.il
Insights
Thrombophilia significantly contributes to childhood venous thromboembolic events (VTEs), with prevalence varying widely. Current guidelines recommend broad testing, but re-evaluating risk factors and prognostic value may refine future management strategies.
Area of Science:
- Pediatric Hematology
- Thrombosis and Hemostasis
- Clinical Genetics
Background:
- Childhood venous thromboembolic events (VTEs) are often linked to underlying conditions like central venous lines, cancer, and cardiac diseases.
- The prevalence of thrombophilia in pediatric VTE cases shows extreme variation (10-78%) across different studies.
- This variability likely stems from differences in patient populations and study methodologies.
Purpose of the Study:
- To review the significance of thrombophilia in the development of VTE in children.
- To discuss the implications of thrombophilia testing and its impact on long-term VTE management in pediatric patients.
Main Methods:
- Literature review focusing on thrombophilia and childhood VTE.
- Analysis of reported prevalence rates and influencing factors.
- Discussion of current diagnostic and management guidelines.
Main Results:
- Thrombophilia is a notable factor in childhood VTE, but its precise contribution is inconsistently reported.
- Initial VTE management in children with thrombophilia generally mirrors that of non-thrombophilic patients, with exceptions for rare homozygous protein deficiencies.
- The long-term therapeutic impact and prognostic value of thrombophilic markers in pediatric VTE remain unclear.
Conclusions:
- Current guidelines advocate comprehensive thrombophilia screening for all children with VTE.
- Re-evaluation of comorbid risk factors and the prognostic significance of thrombophilic markers is needed.
- Future approaches to managing pediatric VTE may benefit from more individualized and less rigid treatment schemes based on a thorough risk assessment.
Abstract:
Venous thromboembolic events (VTEs) in children are usually associated with underlying clinical conditions such as central venous line, cancer and cardiac diseases. The objective of this review is to present the importance of thrombophilia to the occurrence of childhood VTE. The reported prevalence of thrombophilia in children with VTE varies extremely between 10% and 78% in different registries. The variation in the reported prevalence most probably reflects differences in the clinical characteristics of the children studied and differences in study designs. The initial management of children with thrombophilia and VTE is similar to those individuals who do not have a specific inherited thrombophilic risk factor, except in the rare events of homozygous deficiencies of prothrombotic coagulation proteins. The impact of thrombophilic markers on long-term therapy and outcome of children with VTE has not been completely clarified. According to the current guidelines for thrombophilia, all children with VTE should be tested for a full panel of genetic and acquired prothrombotic traits. However, re-evaluation of co-morbid risk factors other than thrombophilic markers and careful consideration of the prognostic value of thrombophilic markers might help to change future attitude from the rigidity of current guidelines to more rational schemes.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management

